GLP-1 drugs like Ozempic carry a 37% higher hair loss risk, but that's no reason to panic — the shedding is temporary and nonscarring, with hair typically regrowing once weight stabilizes. The absolute risk stays low at roughly 6.91 cases per 1,000 person-years, meaning only two to three extra cases compared to alternative diabetes meds. The metabolic benefits of better glycemic control and reduced obesity-related complications far outweigh this manageable side effect.